menu toggle

Recap AMCP 2024: Our thought leadership in action

By AmerisourceBergen

From delivering educational sessions on the evolution of the AMCP format for formulary submissions and the role of pre-approval dossiers in a successful product launch to award-winning research, Cencora was a proud supporter of this year's conference. 

Explore some of our expert contributions and related content that showcased our commitment to helping our biopharma partners accelerate product success. 


Award-winning research

AMCP silver medal award

Payer perspectives of cell therapy and gene therapy treatment paradigms for an Inherited retinal disorder

meeting

Insight

6 questions with Kyle Noonan

Kyle Noonan, PharmD, MS
AmerisourceBergen
May 2024

meeting

Insight

5 questions with Jane Ha

Jane Ha, PharmD, MS
AmerisourceBergen
May 2024

AB-Business-Meeting-Two-Males_RGB_Large-Square

Insight

4 questions with Ben Penley

Ben Penley
AmerisourceBergen
May 2024

FormularyDecisions®

For biopharma

Did you miss our snack and learn for biopharma companies at AMCP 2024? You can still connect with our team to learn how you can connect with the largest active online payer community in the US to share information throughout your product's lifecycle.

For healthcare decision makers

Didn't get a chance to stop by for bubble tea break at AMCP 2024 but still want to access evidence for thousands of products - all from one site? Register today and start streamlining your formulary review process.

Innovation and Impact Award

In the ever-evolving landscape of healthcare, where decisions shape outcomes and information is paramount, the reliance on digital channels for accessing crucial product-related data has become increasingly critical. 

The Innovation and Impact Award serves as a beacon of recognition for those who have demonstrated exceptional support for healthcare decision makers needs in formulary decision making. It is awarded annually to distinguished recipients in two distinct categories: mid-to-large biopharma and emerging biopharma. 

Congratulations to SpringWorks Therapeutics (Emerging biopharma category) and AbbVie Inc (Mid-to-large biopharma category).
amcp
Xcenda_2_3_Card-01

Stay on top of the latest US health policy news

Stay informed with Health Policy Weekly, an at-a-glance view of legislative and regulatory developments and news that impacts the healthcare industry.

We are Cencora. Our shared identity unites us.

Cencora brings the companies and services of AmerisourceBergen together under one new name. Check out our full life cycle commercialization solutions, and contact us today to learn more.